4.6 Review

The HIF-1 alpha as a Potent Inducer of the Hallmarks in Gastric Cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Gastric Cancer, Version 2.2022

Jaffer A. Ajani et al.

Summary: Gastric cancer is the third leading cause of cancer-related deaths worldwide, with over 95% being adenocarcinomas. It is often diagnosed at an advanced stage, leading to a poor prognosis. However, systemic therapy can alleviate symptoms, improve survival, and enhance quality of life. The implementation of biomarker testing has significantly impacted clinical practice and patient care. Targeted therapies have shown encouraging results in clinical trials. Palliative management is recommended for patients with unresectable or metastatic cancer.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

Article Multidisciplinary Sciences

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

Kohei Shitara et al.

Summary: In patients with gastro-oesophageal adenocarcinoma, nivolumab plus chemotherapy has shown superior overall survival compared to chemotherapy alone.

NATURE (2022)

Article Medicine, General & Internal

The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study

Eileen Morgan et al.

Summary: This study analyzed the global patterns of gastric cancer in 2020 and predicted the burden for 2040. The incidence and mortality rates of gastric cancer varied by sex, country, and level of human development. Eastern Asia had the highest rates, while Africa had the lowest. The predicted burden of gastric cancer is expected to increase by 2040.

ECLINICALMEDICINE (2022)

Article Oncology

Current treatment and recent progress in gastric cancer

Smita S. Joshi et al.

Summary: Gastric cancer is a common cause of cancer death worldwide, with treatment options including systemic chemotherapy, radiotherapy, surgery, immunotherapy, and targeted therapy. Classification and biomarkers for gastric cancer help in personalized therapy and identifying populations most likely to benefit from immunotherapy and targeted therapy.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Multidisciplinary Sciences

The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer

Yelena Y. Janjigian et al.

Summary: The study results demonstrate that adding pembrolizumab to trastuzumab and chemotherapy significantly reduces tumor size, induces complete responses in some patients, and improves objective response rate in HER2-positive gastric or gastro-oesophageal junction adenocarcinoma.

NATURE (2021)

Review Biochemistry & Molecular Biology

Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications

Karim Rihawi et al.

Summary: Gastric cancer is the fifth most commonly diagnosed cancer worldwide, with poor prognosis in advanced stage patients despite improvements in treatment. Research efforts have focused on identifying novel therapeutic targets, with the tumor microenvironment emerging as a potential target. Various agents and strategies targeting the TME are currently being evaluated in preclinical and clinical studies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, General & Internal

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly et al.

Summary: In patients with resected esophageal or gastroesophageal junction cancer who had received neoadjuvant chemoradiotherapy, adjuvant therapy with nivolumab significantly improved disease-free survival compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Yelena Y. Janjigian et al.

Summary: Nivolumab plus chemotherapy showed superior overall survival and progression-free survival compared to chemotherapy alone in previously untreated patients with advanced gastric, gastro-oesophageal junction, or oesophageal adenocarcinoma, indicating it as a new standard first-line treatment option with acceptable safety profile.

LANCET (2021)

Review Oncology

An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor

Yukari Shirai et al.

Summary: HIF-1 is a critical target for cancer therapy due to its association with hypoxia, malignant phenotype, and therapy resistance in tumors. Recent research has focused on uncovering the molecular mechanisms of HIF-1 activation, identifying HIF-1 activators, and developing anticancer drugs targeting HIF-1.

CANCERS (2021)

Review Biotechnology & Applied Microbiology

A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer

Tuo Ruan et al.

ONCOTARGETS AND THERAPY (2020)

Article Multidisciplinary Sciences

Divergent mutational processes distinguish hypoxic and normoxic tumours

Vinayak Bhandari et al.

NATURE COMMUNICATIONS (2020)

Review Oncology

Tumor-Associated Macrophages: Recent Insights and Therapies

Jiawei Zhou et al.

FRONTIERS IN ONCOLOGY (2020)

Article Medicine, General & Internal

Gastric cancer

Elizabeth C Smyth et al.

LANCET (2020)

Review Oncology

HIF Inhibitors: Status of Current Clinical Development

Jaleh Fallah et al.

CURRENT ONCOLOGY REPORTS (2019)

Review Medicine, Research & Experimental

Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell?

Zahra Ghanbari Movahed et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Immunology

IL-1 Family Members in Cancer; Two Sides to Every Story

Kevin J. Baker et al.

FRONTIERS IN IMMUNOLOGY (2019)

Editorial Material Oncology

The Epithelial-to-Mesenchymal Transition in Cancer

Joelle Roche

CANCERS (2018)

Article Multidisciplinary Sciences

Vasculogenic mimicry formation in EBV-associated epithelial malignancies

Tong Xiang et al.

NATURE COMMUNICATIONS (2018)

Review Oncology

From inflammation to gastric cancer: Role of Helicobacter pylori (Review)

Xiao-Ying Zhang et al.

ONCOLOGY LETTERS (2017)

Review Biochemistry & Molecular Biology

The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer

Dimakatso Alice Senthebane et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Gastroenterology & Hepatology

Hypoxia/IL-1α axis promotes gastric cancer progression and drug resistance

Yi Xuan et al.

JOURNAL OF DIGESTIVE DISEASES (2017)

Article Oncology

PHD3 affects gastric cancer progression by negatively regulating HIF1A

Ying-Jie Xia et al.

MOLECULAR MEDICINE REPORTS (2017)

Article Medicine, General & Internal

Gastric adenocarcinoma

Jaffer A. Ajani et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Review Biochemistry & Molecular Biology

The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism

Xiu Lv et al.

GENES & DISEASES (2017)

Review Biochemistry & Molecular Biology

Emerging Biological Principles of Metastasis

Arthur W. Lambert et al.

Article Oncology

Hypoxic Microenvironment Induces EMT and Upgrades Stem-Like Properties of Gastric Cancer Cells

Jinbao Guo et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2016)

Article Oncology

Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming

Young Chan Chae et al.

CANCER CELL (2016)

Review Oncology

Hostile takeover: Manipulation of HIF-1 signaling in pathogen-associated cancers (Review)

Caixia Zhu et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2016)

Review Biochemistry & Molecular Biology

The Warburg Effect: How Does it Benefit Cancer Cells?

Maria V. Liberti et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Review Oncology

Addressing intra-tumoral heterogeneity and therapy resistance

Brad Rybinski et al.

ONCOTARGET (2016)

Review Oncology

Hypoxia and metabolic adaptation of cancer cells

K. L. Eales et al.

ONCOGENESIS (2016)

Article Cell Biology

Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia

Muhammad Zaeem Noman et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)

Article Oncology

Visfatin effects on telomerase gene expression in AGS gastric cancer cell line

M. Mohammadi et al.

INDIAN JOURNAL OF CANCER (2015)

Article Immunology

Myeloid HIF-1 Is Protective in Helicobacter pylori-Mediated Gastritis

Pavle Matak et al.

JOURNAL OF IMMUNOLOGY (2015)

Article Medicine, Research & Experimental

microRNA-18a regulates gastric carcinoma cell apoptosis and invasion by suppressing hypoxia-inducible factor-1α expression

Fubing Wu et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)

Article Oncology

Visfatin effects on telomerase gene expression in AGS gastric cancer cell line

M. Mohammadi et al.

INDIAN JOURNAL OF CANCER (2015)

Review Pharmacology & Pharmacy

HIF-1α pathway: role, regulation and intervention for cancer therapy

Georgina N. Masoud et al.

ACTA PHARMACEUTICA SINICA B (2015)

Review Pharmacology & Pharmacy

Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer

Steffen Heeg

PHARMACOGENOMICS & PERSONALIZED MEDICINE (2015)

Article Multidisciplinary Sciences

Comprehensive molecular characterization of gastric adenocarcinoma

Adam J. Bass et al.

NATURE (2014)

Review Cell Biology

Molecular mechanisms of epithelial-mesenchymal transition

Samy Lamouille et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)

Article Biochemistry & Molecular Biology

Elevated plasma visfatin levels correlate with poor prognosis of gastric cancer patients

Guo-Wen Lu et al.

PEPTIDES (2014)

Article Gastroenterology & Hepatology

Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia

Lei-Lei Tao et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Meta-analysis of immunohistochemical expression of hypoxia inducible factor-1α as a prognostic role in gastric cancer

Shuang Lin et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Role of epithelial-mesenchymal transition in gastric cancer initiation and progression

Zhao Peng et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Medicine, General & Internal

Clinicopathological Implications of the Expression of Hypoxia-related Proteins in Gastric Cancer

Ji-Han Jung et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)

Article Multidisciplinary Sciences

Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling

Junko Matsuoka et al.

PLOS ONE (2013)

Article Oncology

The Critical Impact of HIF-1a on Gastric Cancer Biology

Yoshihiko Kitajima et al.

Cancers (2013)

Review Oncology

Cancer drug resistance: an evolving paradigm

Caitriona Holohan et al.

NATURE REVIEWS CANCER (2013)

Review Biochemistry & Molecular Biology

Hypoxia-Inducible Factors in Physiology and Medicine

Gregg L. Semenza

Review Cell Biology

The functions and regulation of the PTEN tumour suppressor

Min Sup Song et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)

Article Multidisciplinary Sciences

Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1

Yi Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Multidisciplinary Sciences

Genetic Aspects of Gastric Cancer Instability

Petra Hudler

SCIENTIFIC WORLD JOURNAL (2012)

Review Pharmacology & Pharmacy

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

Gregg L. Semenza

TRENDS IN PHARMACOLOGICAL SCIENCES (2012)

Review Oncology

EMT A new vision of hypoxia promoting cancer progression

Jian Jiang et al.

CANCER BIOLOGY & THERAPY (2011)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Review Obstetrics & Gynecology

Tumor hypoxia and genetic alterations in sporadic cancers

Minoru Koi et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2011)

Article Gastroenterology & Hepatology

Mechanism of hypoxia-inducible factor 1α-mediated Mcl1 regulation in Helicobacter pylori-infected human gastric epithelium

Asima Bhattacharyya et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)

Review Biochemistry & Molecular Biology

Immunity, Inflammation, and Cancer

Sergei I. Grivennikov et al.

Review Cell Biology

HIF-1: upstream and downstream of cancer metabolism

Gregg L. Semenza

CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)

Article Oncology

HIF-1α determines the metastatic potential of gastric cancer cells

N. Rohwer et al.

BRITISH JOURNAL OF CANCER (2009)

Article Biochemistry & Molecular Biology

Regulation of glucose metabolism-related genes and VEGF by HIF-1α and HIF-1β, but not HIF-2α, in gastric cancer

In-Sung Song et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2009)

Review Oncology

Mechanisms of the epithelial-mesenchymal transition by TGF-beta

Michael K. Wendt et al.

FUTURE ONCOLOGY (2009)

Review Biochemistry & Molecular Biology

Role of Hypoxia in the Hallmarks of Human Cancer

Kai Ruan et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2009)

Review Medicine, Research & Experimental

The basics of epithelial-mesenchymal transition

Raghu Kalluri et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Review Multidisciplinary Sciences

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Matthew G. Vander Heiden et al.

SCIENCE (2009)

Review Biochemistry & Molecular Biology

Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway

William G. Kaelin et al.

MOLECULAR CELL (2008)

Article Multidisciplinary Sciences

Notch signaling mediates hypoxia-induced tumor cell migration and invasion

Cecilia Sahlgren et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Cell & Tissue Engineering

Hypoxia causes downregulation of mismatch repair system and genomic instability in stem cells

Francisco Javier Rodriguez-Jimenez et al.

STEM CELLS (2008)

Article Multidisciplinary Sciences

Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

Ralph J. DeBerardinis et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Review Oncology

Drug resistance and the solid tumor microenvironment

Olivier Tredan et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)

Article Biochemistry & Molecular Biology

Visfatin in adipocytes is upregulated by hypoxia through HIFIα-dependent mechanism

Katsumori Segawa et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Biochemistry & Molecular Biology

Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1

Soo-Kyung Bae et al.

FEBS LETTERS (2006)

Review Gastroenterology & Hepatology

Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer

Gen Tamura

WORLD JOURNAL OF GASTROENTEROLOGY (2006)

Review Biotechnology & Applied Microbiology

Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis

RS Bindra et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)

Article Biochemistry & Molecular Biology

HIF-1-mediated activation of telomerase in cervical cancer cells

N Yatabe et al.

ONCOGENE (2004)

Article Medicine, Research & Experimental

Bimodal effect of hypoxia in cancer: Role of hypoxia inducible factor in apoptosis

Yang Wang et al.

MOLECULAR PHARMACEUTICS (2004)

Review Pathology

The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis

AE Greijer et al.

JOURNAL OF CLINICAL PATHOLOGY (2004)

Article Oncology

Role of hypoxia-inducible factor 1α in gastric cancer cell growth, angiogenesis, and vessel maturation

O Stoeltzing et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)

Article Biochemistry & Molecular Biology

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells

RS Bindra et al.

MOLECULAR AND CELLULAR BIOLOGY (2004)

Article Gastroenterology & Hepatology

PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma

L Yang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2003)

Article Biochemistry & Molecular Biology

Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia - HIF-1-independent mechanisms

Z Dong et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)